Journal Report

MOLECULAR CANCER THERAPEUTICS

Download PDF
Journal Information
Journal Title
MOLECULAR CANCER THERAPEUTICS
Publisher
AMER ASSOC CANCER RESEARCH
ISSN
1535-7163
E-ISSN
1538-8514
Database
Clarivate
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Combined ATR and Mitotic Inhibition Is Effective against <i>MYCN</i> -Amplified Neuroblastoma
Katarzyna Radke, Karin Hansson, Subhayan Chattopadhyay et al.
2026-11-9 Pages OF1-OF11
DOI: 10.1158/1535-7163.mct-26-0270
Systematic Evaluation of Combination Strategies with Rezatapopt in p53 Y220C-Mutant Cancer Models
Tamer Ahmed, Erin E. Michaud, Lizhong Xu et al.
2026-11-6 Pages OF1-OF14
DOI: 10.1158/1535-7163.mct-26-0264
Nanoparticle Codelivery of Microtubule Inhibitors and Cisplatin Overcomes DNA Repair–Mediated Resistance in Head and Neck Cancer
Xin Li, Liubov Palchak, Ling Wang et al.
2026-11-6 Pages OF1-OF16
DOI: 10.1158/1535-7163.mct-25-1239
Variant-Selective and Pan-RAS Inhibitors Enhance Targeted Agent Activity in Patient-Derived Multi–cell-type Tumor Spheroids
Thomas S. Dexheimer, Zahra Davoudi, Nathan P. Coussens et al.
2026-11-5 Pages OF1-OF16
DOI: 10.1158/1535-7163.mct-26-0200
Novel antibody-drug conjugates targeting EphA3 in tumours and the tumour microenvironment
Peter W. Janes, Mary E. Vail, Stacey Allen et al.
2026-11-3
DOI: 10.1158/1535-7163.mct-25-1492
Selected Articles from This Issue
2026-11-3 Vol. 25 Issue 11 Pages 1789-1789
DOI: 10.1158/1535-7163.mct-25-11-hi
Aberrant expression of HERV-K envelope in lymphoma represents an opportunity for novel treatments.
Filippo Spriano, Luciano Cascione, Jacopo Sgrignani et al.
2026-11-3
DOI: 10.1158/1535-7163.mct-25-1542
PLK1 Inhibition by Onvansertib Enhances Paclitaxel Efficacy and Overcomes Resistance in HR+/HER2− Breast Cancer Refractory to Endocrine Therapy and CDK4/6 Inhibitors
Sreeja Sreekumar, Migdalia E. Gonzalez, Davis Klein et al.
2026-11-2 Pages OF1-OF13
DOI: 10.1158/1535-7163.mct-26-0239
GD2 Induction by Combination Chromatin-Directed Inhibitors Enhances Targeting of Ewing Sarcoma and Osteosarcoma by CAR T Cells
Justin R. Sperlazza, Kevin C. Field, Caitlyn McComb et al.
2026-10-30 Pages OF1-OF16
DOI: 10.1158/1535-7163.mct-25-0332
ATR inhibitors and gemcitabine synergize to induce cell death in TP53-mutant, ATRX-wildtype uterine leiomyosarcoma
Megan E. Doherty, Minnie Malik, Yuka Otsuka et al.
2026-10-29
DOI: 10.1158/1535-7163.mct-26-0434
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 10, 2026 15:27